Dr. James William Langston, MD

Dr. Langston practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Dr. Langston's NPI, 1659306371, was assigned on July 11, 2006. Dr. Langston graduated from University of Missouri School of Medicine in 1967. Dr. Langston holds California license G21759.

Dr. Langston's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Dr. Langston's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. The medical group on file is Stanford Health Care. Dmand AI also links Dr. Langston to 1 more hospital and 1 medical group, each named with a free account. Dr. Langston's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Langston practices, 2 sites in all. Vendor and product names are available with a free account.

Clinical neurophysiology is Dr. Langston's primary specialty in the NPI Registry, under taxonomy code 2084N0600X. Dr. Langston is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Langston's licenses on file in 2 states: California and Georgia.

Dmand AI lists parkinson's disease among the conditions Dr. Langston treats.

CMS data shows 165 Medicare services from Dr. Langston across 2 procedure codes in 2024, all of them office visits, for 44 Medicare patients. Medicare paid $12,947 for them.

CMS counts 44 Medicare patients who saw Dr. Langston in 2024. The largest group is 75 to 84, with 26 patients. 75% of them have parkinson's disease, and 61% have high cholesterol. Their average risk score is 1.57, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Langston's median patient age at 78, with 29% women.

In 2024, Dr. Langston wrote 633 Medicare Part D claims for 41 patients. 75% of them were for generic drugs. CMS names the drug for 531 of them, across 12 drugs with 11 or more claims each, at $413,633 in total drug cost. In 2023, CMS named 533 claims across 15 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Langston for performance year 2024, reported as part of a group. Dr. Langston accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Langston as offering telehealth.

Dmand AI links 220 papers to Dr. Langston, published from 2002 to 2022. 2014 was the busiest year, with 4. The most frequent topics are Parkinson Disease, 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine and Corpus Striatum. Dr. Langston has published most often in Ann Neurol. Dr. Langston's most frequent co-authors are Caroline M. Tanner, MD, PhD, Amar J. Gajjar, MD and Samuel Mark Goldman, MD.

Dmand AI links Dr. Langston to 1 clinical trial. Conditions studied include Caregiver Burden and Stress, Psychological.

CMS Open Payments shows 6 general payments to Dr. Langston from 2 drug and device companies from 2017 to 2025. Speaker and faculty fees make up the largest share, 90% of the total. MDD US Operations, LLC paid the most, $537. It also lists 1 research payment totaling $7,500 in 2016.

Dr. Langston graduated from University of Missouri School of Medicine in 1967. Dr. Langston is a member of MDS.

Dr. Langston is in network with 7 carriers, including Aetna, Blue Cross Blue Shield of Massachusetts and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 4. Check the plan with the practice before a visit.